TGA Approval

ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial (203372)

ARTG ID

203372

ARTG Name

ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial

Sponsor

Takeda Pharmaceuticals Australia Pty Ltd

ARTG Date

December 20, 2013

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-CMI-01559-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-01042-1

Ingredient Name

Brentuximab vedotin

Empowering clinical research with data-driven insights and AI-powered tools.

ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial (203372) - TGA 批准文号 | MedPath